Detalhe da pesquisa
1.
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer.
Nat Immunol
; 24(5): 792-801, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081148
2.
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis.
Nature
; 625(7993): 166-174, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38057662
3.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972660
4.
Radioembolization plus Immune Checkpoint Inhibitor Therapy Compared with Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular Carcinoma.
J Vasc Interv Radiol
; 35(5): 722-730.e1, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342221
5.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Hepatology
; 76(4): 1000-1012, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313048
6.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver Int
; 43(3): 695-707, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577703
7.
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.
Liver Int
; 42(11): 2538-2547, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986902
8.
Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?
Radiology
; 303(1): 226-228, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014907
9.
Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular Carcinoma.
Hepatology
; 74(1): 483-490, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33369758
10.
Treatment of Hepatocellular Carcinoma with Neoadjuvant Nivolumab Alone Versus in Combination with a CCR2/5 Inhibitor or an Anti-IL-8 Antibody.
Ann Surg Oncol
; 29(1): 30-32, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117573
11.
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma.
Nat Rev Clin Oncol
; 21(4): 294-311, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38424197
12.
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial.
Nat Med
; 30(4): 1044-1053, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38584166
13.
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study.
J Thorac Oncol
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278303
14.
Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines.
J Allergy Clin Immunol
; 129(1): 184-90.e1-4, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22088613
15.
Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae.
Nat Med
; 29(1): 236-246, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482101
16.
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma.
Hepatol Int
; 17(4): 904-914, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005953
17.
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.
World J Gastrointest Oncol
; 15(11): 1900-1912, 2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38077640
18.
Intratumoral dendritic cell-CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma.
Nat Med
; 29(6): 1389-1399, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322116
19.
Neoadjuvant Immunotherapy for Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 9: 571-581, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35794901
20.
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors.
Cancer Discov
; 12(11): 2606-2625, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36027053